www.espn.com - MLB
Latest MLB news from www.espn.com
↔️ Free agency tracker: Offseason trades, moves
We've got you covered on all the major MLB hot stove signings and trades.[read more]
Fraley lands back with Rays on 1-year, $3M deal
After cutting him loose last week, the Tampa Bay Rays signed outfielder Jake Fraley to a one-year, $3 million contract on Tuesday.[read more]
Steinbrenner: 'Ideal' for Yankees to lower payroll
Yankees owner Hal Steinbrenner claimed it was too early in the offseason to determine his team's payroll range for the 2026 season, but he'd prefer that the number drop from the $319 million he said New York spent on players in 2025.[read more]
Red Sox acquire durable Gray in trade with Cards
The Red Sox have acquired veteran Sonny Gray in a trade with the Cardinals in exchange for two pitchers. The three-time All-Star was 14-8 with a 4.28 ERA last season.[read more]
Skenes receives record $3.4M in pre-arbitration
Pirates pitcher Paul Skenes received a record $3,436,343 from the pre-arbitration bonus pool, according to figures compiled by MLB and the players' association.[read more]
Source: Angels in talks to buy out Rendon deal
The Angels and Anthony Rendon are in talks about buying out the final year of his seven-year, $245M contract, a source told ESPN. The third baseman is expected to retire.[read more]
Sources: Jays, Cease reach 7-year, $210M deal
Right-hander Dylan Cease, who has made at least 32 starts in each of the past five seasons, reached a seven-year, $210 million deal with the Blue Jays, sources told ESPN.[read more]
Sources: Orioles, Helsley agree to 2-year deal
Closer Ryan Helsley and the Baltimore Orioles are in agreement on a two-year contract that includes an opt-out after the first season, sources told ESPN.[read more]
Exemptions for ADHD drugs drop to record-low
A record low 54 major league players were given permission to use medication for ADHD, down from 61 last year and 119 in 2013.[read more]
How good are this year's top Japanese free agents -- and who could sign them?
We break down what to expect from Tatsuya Imai, Munetaka Murakami and Kazuma Okamoto in 2026.[read more]